Treatment Outcomes with Telaprevir-Based Therapy for HIV/Hepatitis C Coinfected Patients are Comparable with Hepatitis C Monoinfected Patients
Saved in:
Main Authors: | Conar R O’Neil, Jack XQ Pang, Samuel S Lee, Mark G Swain, Kelly W Burak, Patricia Klein, Robert P Myers, Jeff Kapler, Michael J Gill, Martin Labrie, Carla S Coffin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2015/974871 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Telaprevir in treatment of chronic hepatitis C: safety issues
by: T. M. Ignatova
Published: (2012-07-01) -
Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany
by: Jona T. Stahmeyer, et al.
Published: (2013-12-01) -
Acute Coinfection with Hepatitis B and Hepatitis C Viruses
by: Brian M Yan, et al.
Published: (2005-01-01) -
Real-Life Experiences with Telaprevir in the Treatment of Chronic Genotype 1 Hepatitis C — The TEPS Study
by: T. Berg, et al.
Published: (2019-01-01) -
Optimizing Hepatitis C Therapy in HIV/hepatitis C Virus (HCV) Coinfected Patients: Analysis of HCV Viral Kinetics on Treatment
by: Paul Damien James, et al.
Published: (2012-01-01)